Filter
1427
Filtered Results: 1427
Text search:
A.
Bone
Featured
Recommendations
194
New Publications
357
Language
Document type
No document type
794
Guidelines
271
Studies & Reports
168
Manuals
84
Training Material
44
Fact sheets
30
Strategic & Response Plan
19
Brochures
7
Situation Updates
5
Infographics
2
Online Courses
2
Videos
1
Countries / Regions
India
139
Kenya
37
South Africa
35
Ethiopia
33
Global
31
Nepal
25
Uganda
23
Nigeria
21
Tanzania
19
Western and Central Europe
17
Philippines
16
Bangladesh
16
Ghana
15
Rwanda
15
Indonesia
15
Africa
15
Brazil
14
Latin America and the Carribbean
14
Zambia
13
Myanmar / Burma
13
Namibia
12
Sierra Leone
10
Malawi
10
Ukraine
10
Russia
10
Liberia
9
South–East Asia Region
9
Eswatini/ Swaziland
8
Syria
7
Cambodia
7
Mozambique
7
Botswana
6
Zimbabwe
5
Haiti
5
Lesotho
5
USA
4
Argentina
4
Eastern Europe and Central Asia
4
Asia
4
Eastern Europe
4
Congo, Democratic Republic of
3
Cameroon
3
South Sudan
3
Sudan
3
Vietnam
3
Burkina Faso
2
Senegal
2
Pakistan
2
Iraq
2
Jordan
2
Germany
2
Turkey
2
Papua New Guinea
2
Central African Republic
2
East and Southern Africa
2
Middle East and North Africa
2
Albania
2
Southern Africa
2
Tajikistan
2
Moldova
2
Niger
1
Lebanon
1
Egypt
1
Gambia
1
Benin
1
North Macedonia
1
Honduras
1
Greece
1
Libya
1
Angola
1
Guatemala
1
Madagascar
1
Chile
1
Yemen
1
West and Central Africa
1
Paraguay
1
Bhutan
1
Venezuela
1
Palestine
1
Mongolia
1
Timor Leste/ East Timor
1
Estonia
1
Georgia
1
North America
1
Jamaica
1
United Kingdom
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
533
Clinical Guidelines
231
Women & Child Health
128
Public Health
84
Capacity Building
45
Key Resources
32
Pharmacy & Technologies
15
Toolboxes
HIV
100
TB
94
COVID-19
87
Caregiver
68
Disability
66
NTDs
58
Mental Health
56
Pharmacy
43
AMR
40
Rapid Response
38
Conflict
34
NCDs
28
Planetary Health
26
Ebola
24
Refugee
23
Specific Hazards
19
Natural Hazards
15
Zika
14
Cholera
9
Global Health Education
7
Social Ethics
6
Polio
4
Health Financing Toolbox
1
Las guías para la prevención de Infecciones del Sitio Quirúrgico (ISQ) resumen las medidas basadas en la evidencia que han demostrado disminuir su incidencia y mejorar la calidad asistencial de los pacientes sometidos a cirugía. La última revis...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the...
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of info...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is ... need to improve leishmaniasis prevention and control based on robust surveillance in humans, animals, and vectors, and to increase public awareness following a one health approach.
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is ... major risk factor for developing chronic kidney disease (CKD), which in itself is associated with developing CVD. The combination of diabetes with these cardio-renal comorbidities enhances the risk not only for cardiovascular (CV) events but also for CV and all-cause mortality. The current European Society of Cardiology (ESC) Guidelines on the management of cardiovascular disease in patients with diabetes are designed to guide prevention and management of the manifestations of CVD in patients with diabetes based on data published until end of January 2023. Over the last decade, the results of various large cardiovascular outcome trials (CVOTs) in patients with diabetes at high CV risk with novel glucose- lowering agents, such as sodium–glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), but also novel non-steroidal mineralocorticoid receptor antagonists (MRAs), such as finerenone have substantially expanded available therapeutic op-
tions, leading to numerous evidence-based recommendations for the management of this patient population.
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the ortho...
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatme...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatme...
The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and p...
This Birth Defect Surveillance facilitator (train-the-trainer) guide 2nd edition covers foundational skills needed to begin the development, implementation and ongoing improvement of a congenital anomaly surveillance programme, whether population-ba...
Managers Who Lead empowers health managers at all levels of an organization to lead teams to face challenges and achieve results. It answers questions such as: How can I lead and manage more effectively? How do I create a shared vision and ... clear path for achieving it? What can I do to improve work climate? How can I prepare myself and others for higher levels of responsibility? How do I lead change inside and outside my organization?
Manual Logistical Management of Humanitarian Supply
The flood of relief supplies that arrive in the aftermath of large-scale disasters often poses serious logistic and management problems for national authorities. SUMA is a tool for the management ...
This report is from the National study on living conditions among people
with disabilities carried out in Nepal in 2014-2015. The study was carried
out as a household survey with two-stage stratified sampling, including ... screening/listing procedure using the Washington Group on Disability
Statistics 6 questions, one Household questionnaire administered to
households with (Case HHs) and without disabled members (Control
HHs), one Individual Case questionnaire administered to individuals who were found to qualify as being disabled in the screening (Case
individuals), and an Individual Control questionnaire administered to
matched non-disabled individuals in the Control HHs (Control individuals). The study covers a range of indicators on level of living, such as socioeconomic indicators, economic activity, income, ownership and infrastructure, health (including reproductive health), access to health information, access to services, education, access to information, social participation, and exposure to discrimination and abuse (see all
questionnaires in Appendix).
Wild elephants and snakes, violent men lurking in the forest and human traffickers on the prowl during the night. These are among the most pressing fears identified by Rohingya children who fled fighting in Myanmar to Bangladesh, according to a new ...
This booklet provides policymakers, planners, and other interested parties with insight into the current state of the Rwandan health sector. These statistics provide a basis for policies, strategies, and planned interventions to ensure they are resp...
The target audience for this guideline is primarily for health care providers nurses, doctors, social workers and other people involved in HIV response in Rwanda so that they are capable of offering quality care services to patients over a long time...
